ConductScience.org, home

Gene487

ATP2A1: ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1

13 sourcesgene-search-2026-11-13-0.2.1

Download JSON
Cite this record

ConductScience Library. ATP2A1: ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1. Genes, record 487. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/487

FollowSave as evidence

Gene

Symbol
ATP2A1
HGNC
Name
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
HGNC
NCBI Gene ID
487
NCBI Gene
HGNC ID
HGNC:811
HGNC
Ensembl
ENSG00000196296
NCBI Gene
Aliases
ATP2A, SERCA1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
O14983Sarcoplasmic/endoplasmic reticulum calcium ATPase 11,0010Ensembl, GeneID, HGNC

Source UniProt

Patents74

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
US 20260193644 A12026-07-097333O14983Espacenet
US 20260139247 A12026-05-21505O14983Espacenet
JP 2026004568 A2026-01-1438163O14983Espacenet
EP 4641201 A22025-10-297333O14983Espacenet
JP 2025529142 A2025-09-04505O14983Espacenet
US 12371689 B22025-07-29505O14983Espacenet
US 12371689 B22025-07-29505O14983Espacenet
JP 2025517969 A2025-06-127333O14983Espacenet
JP 2025062604 A2025-04-147232O14983Espacenet
US 20240398993 A12024-12-0521084O14983Espacenet

See all 74 patents

Drugs1

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismAction
MIPSAGARGINCHEMBL3989865Sarcoplasmic/endoplasmic reticulum calcium ATPase inhibitorINHIBITOR

Source ChEMBL

Trials7

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT02876003MIPSAGARGINPHASE2ClinicalTrials.gov
NCT02607553MIPSAGARGINPHASE2ClinicalTrials.gov
NCT02381236MIPSAGARGINPHASE2ClinicalTrials.gov
NCT02082691MIPSAGARGINClinicalTrials.gov
NCT02067156MIPSAGARGINPHASE22024-05-21ClinicalTrials.gov
NCT01777594MIPSAGARGINPHASE2ClinicalTrials.gov
NCT01734681MIPSAGARGINPHASE2ClinicalTrials.gov

NIH grants987

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleATP2A1 papersNewest fiscal year
P30DK020541NYR-Diabetes Research Center (NYR-DRC)82025
P30CA016672Cancer Center Support Grant42025
P30DK063491Diabetes Research Center (DRC)32025
R01DK093757Genetic epidemiology of rare and regulatory variants for metabolic traits32025
R01DK097441Molecular mechanisms of UCP1-independent pathways in metabolic health32025
R01ES014901Molecular and Cellular Basis of PCB Developmental Neurotoxicity32025
T32HL007055Cardiovascular Epidemiology Training Grant32025
U10AA008401Collaborative Study on the Genetics of Alcoholism (COGA).32025
UL1TR002345Washington University Institute of Clinical and Translational Sciences32025
P01HD084387Developmental Mechanisms of Human Idiopathic Scoliosis22025

Source NIH's project files

See all 987 nih grants

Papers1,220

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Prognostic value of neuro-related genes in colorectal cancer and their potential implications for immunotherapy.J Cancer202642807766PubTator, text miningPubMed
miR-20487-5p/SERCA1/MAPK/ERK Pathway Regulates Newt Limb Regeneration.Biology (Basel)202642510654PubTator, text miningPubMed
Shared Genetics of Kidney Function Traits and Bladder Cancer: A Genome-Wide Cross-Trait Analysis.Cancer Med202642470241PubTator, text miningPubMed
Activation of Sirt3 reprograms mitochondrial function to regenerate intervertebral disc degeneration.Exp Gerontol202642401268PubTator, text miningPubMed
Sebastidae-specific food allergy causing anaphylaxis: a pediatric case report and fish allergen analysis.BMC Pediatr202642129685PubTator, text miningPubMed
The SERCA Pump: A Key Molecular Target in Calcium Handling of Vascular Smooth Muscle Cells in Metabolic Syndrome.Handb Exp Pharmacol202642113224PubTator, text miningPubMed
The pleiotropic impact of chaperone-mediated autophagy on skeletal muscle integrity.Autophagy202642003010PubTator, text miningPubMed
Sarco/endoplasmatic reticulum calcium ATPase activity in healthy muscle and Brody disease.Biochem Biophys Rep202641938373PubTator, text miningPubMed
Rare Brody myopathy: A case report.J Am Assoc Nurse Pract202641926432PubTator, text miningPubMed
Evaluating Toxicity and Anti-Osteogenic Activity of Artemisinin-Inspired Endoperoxides in Zebrafish Larvae.Toxics202641893529PubTator, text miningPubMed

See all 1,220 papers

Sources 13

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
  • USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
  • USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/487

GET https://conductscience.org/api/genes/v1/487/patents?page=2